In order to determine if azithromycin's IFN-inducing effect and thus its viral load-reducing properties are limited to diseased epithelium, bronchial epithelial cells from healthy subjects were treated with 2 μM azithromycin before and during infection with RV16. The gene discussed is IFNA1; the disease is infection.